Hyzaar

Losartan potassium, the active ingredient in Hyzaar, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, in adult patients. GNH USA supplies Hyzaar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hyzaar is an antihypertensive medication that works within the renin‑angiotensin‑aldosterone system and diuretic pathways to lower blood pressure. - Hypertension: reduces systolic and diastolic blood pressure in adults. - Essential hypertension requiring combination therapy: provides added blood‑pressure control when monotherapy is insufficient. - Hypertensive patients with fluid retention: adds a thiazide diuretic effect to decrease plasma volume and improve pressure control.

Hyzaar may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Fatigue. - Increased urination. - Electrolyte disturbances (e.g., low potassium). - Mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension. - Acute kidney injury. - Hyperkalemia. - Angioedema. - Severe allergic reactions (rash, itching, swelling). - Liver function abnormalities.

Before initiating Hyzaar, consider patient‑specific factors and monitor appropriately. - Renal impairment: assess kidney function and adjust therapy as needed. - Electrolyte balance: monitor serum potassium and sodium levels. - Hepatic disease: use with caution in patients with liver dysfunction. - Concomitant medications: review for potential interactions that affect blood pressure or electrolytes. - Pregnancy: avoid use unless clearly needed; discuss risks with a healthcare professional. - Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and light.

Hyzaar can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - ACE inhibitors or aliskiren: may cause excessive renal dysfunction. - NSAIDs: can blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Lithium: increased lithium levels, monitor serum concentration. - Antidiabetic agents: may enhance hypoglycemic effect. - Other antihypertensives: additive blood‑pressure lowering, watch for hypotension.